Daniel Thomas

As 40,000 students gain private school access via tax credits, we unpack the multi-million dollar system reshaping Pennsylvania's educational landscape.

A Chicago jury's landmark verdict reveals how a single day's delay can lead to a lifetime of paralysis, questioning the very fabric of patient safety.

As America's population ages, Bekins Van Lines launches a specialized certification for senior relocations, a strategic play in a rapidly growing market.

Momentus just secured another $25M, its second major cash infusion in weeks. Is this a desperate lifeline or a strategic launchpad for orbital dominance?

Beyond the red carpet, Japan's showcase at Cannes was a calculated play for market share, blending sophisticated cultural diplomacy with aggressive business tactics.

With its $30M purchase of CareSeed, Sagility is betting on AI-driven analytics to move beyond compliance and redefine healthcare quality and financial outcomes.

Avril Haines’s move from Director of National Intelligence to lead the Carnegie Endowment signals a strategic shift in how peace is pursued in an era of conflict.

The U.S. housing market has shattered a historic price barrier, yet declining sales and economic anxiety reveal a market fundamentally at war with itself.

Firat Eren rebuilt the cult-favorite barter app Bunz from the ashes. Now, he's given its users until September 1st to prove it's worth saving, or he'll delete it himself.

A new currency vending machine in Saskatoon is more than a convenience; it's a signal of automation's next frontier in the battle for travel dollars.

At Africa's top trading summit, EBC Financial Group signaled a major strategic push, using a high-stakes gold debate to cement its role in a rising market.

QCraft and Qualcomm just showed the world a glimpse of the future: mass-market urban autonomous driving. It's a story of strategic partnerships and the dawn of a new 'physical AI'.

PUMA leverages its proven running tech for the pitch, launching the Ultra Nitro 7 in a calculated move to challenge Nike and Adidas's market dominance.

Millions suffer from chronic sciatica with few good options. A small biotech is betting on a novel, non-opioid drug to fix the problem, not just mask it.

While many media giants chase national scale, Gray Media’s award-winning localism reveals a powerful strategy: treating community trust as a critical asset.

An expanded partnership between GENESIS Pharma and Alnylam is set to bring revolutionary RNAi therapies to the Nordics. But can it navigate the region's tough economic hurdles?

A regional PR agency's award sweep isn't just local news. It's a window into the strategic power of narrative in the global economy. Here's why.

A one-time age check is no longer enough. As global regulators tighten the screws, a new era of continuous identity assurance is dawning online. Can we protect children without building a surveillance machine?

Despite a Q2 loss from low avocado prices, Mission Produce finalizes its Calavo acquisition, betting on scale and diversification to reshape its future.

Zealand Pharma's petrelintide shows double-digit weight loss with remarkably few side effects, positioning it to challenge GLP-1 giants in the $100B market.